Journal Mobile Options
Table of Contents
Vol. 16, No. 2, 2001
Issue release date: March–April 2001
Section title: Paper
Fetal Diagn Ther 2001;16:111–115
(DOI:10.1159/000053892)

Knowledge on Periconceptional Use of Folic Acid in Women of British Columbia

Morin V.I. · Mondor M. · Wilson R.D.
Children’s and Women’s Health Center of British Columbia, Vancouver, B.C., Canada

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: 2/16/2001

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 4

ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)

For additional information: http://www.karger.com/FDT

Abstract

Objective: Our purpose was to evaluate the knowledge of folic acid and its use preconceptionally in women of British Columbia. Methods: The study was conducted at British Columbia Women’s Hospital in Vancouver, Canada, between April 15 and June 15, 1999. Pregnant women and women in the postpartum period were asked to complete a survey on folic acid. Results: In total, 1,004 women completed the questionnaire during the study period. Seventy-one percent of the women knew that vitamins could help prevent birth defects. Of those, 76.3% identified folic acid as the one vitamin specifically associated with reduction of birth defects. It was identified that 49.4% of all women took vitamins prior to pregnancy. Conclusions: Women in the population studied were relatively well informed about the benefits of folic acid, but less than 50% of them took vitamins prior to conception.


  

Author Contacts

Dr. Valérie Morin
Centre Hospitalier Universitaire de Québec, Hôpital Saint-François d’Assise
Unité des Essais Cliniques, 10, rue de l’Espinay, local D1–724
Québec, Qué. G1L 3L5 (Canada)
Tel. +1 418 525 4437, Fax +1 418 525 4194, E-Mail morinvalerie@hotmail.com

  

Article Information

Received: Received: January 5, 2000
Accepted: July 26, 2000
Number of Print Pages : 5
Number of Figures : 0, Number of Tables : 4, Number of References : 24

  

Publication Details

Fetal Diagnosis and Therapy (Clinical Advances and Basic Research)
Formerly ‘Fetal Therapy’
Official Organ of the ‘International Fetal Medicine, Surgery Society’ and the International Society ‘Fetus as a Patient’

Vol. 16, No. 2, Year 2001 (Cover Date: March-April 2001)

Journal Editor: W. Holzgreve, Basel
ISSN: 1015–3837 (print), 1421–9964 (Online)

For additional information: http://www.karger.com/journals/fdt


Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: 2/16/2001

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 4

ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)

For additional information: http://www.karger.com/FDT


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.